Zobrazeno 81 - 90
of 563
pro vyhledávání: '"Sonja Zweegman"'
Autor:
Antonio Palumbo, Anders Waage, Cyrille Hulin, Meral Beksac, Sonja Zweegman, Francesca Gay, Peter Gimsing, Xavier Leleu, Pierre Wijermans, Gülsan Sucak, Sara Pezzatti, Gunnar Juliusson, Brigitte Pégourié, Martijn Schaafsma, Monica Galli, Ingemar Turesson, Brigitte Kolb, Bronno van der Holt, Ileana Baldi, Jürgen Rolke, Giovannino Ciccone, Marc Wetterwald, Henk Lokhorst, Mario Boccadoro, Philippe Rodon, Pieter Sonneveld
Publikováno v:
Haematologica, Vol 98, Iss 1 (2013)
Treatment with melphalan-prednisone-thalidomide improves the outcome of patients with multiple myeloma and is now considered a standard of care for patients not eligible for transplantation. However, this treatment is a major source of morbidity. A m
Externí odkaz:
https://doaj.org/article/f3974891ef25498db38f70abd0e7baa1
Autor:
Gerrit J Schuurhuis, Michael H Meel, Floris Wouters, Lisa A Min, Monique Terwijn, Nick A de Jonge, Angele Kelder, Alexander N Snel, Sonja Zweegman, Gert J Ossenkoppele, Linda Smit
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78897 (2013)
Persistence of leukemic stem cells (LSC) after chemotherapy is thought to be responsible for relapse and prevents the curative treatment of acute myeloid leukemia (AML) patients. LSC and normal hematopoietic stem cells (HSC) share many characteristic
Externí odkaz:
https://doaj.org/article/afdfbec2f3a140adb7a2c8c49ec3e1ce
Autor:
Henk M. Lokhorst, Ingo Schmidt-Wolf, Pieter Sonneveld, Bronno van der Holt, Hans Martin, Rene Barge, Uta Bertsch, Jana Schlenzka, Gerard M.J. Bos, Sandra Croockewit, Sonja Zweegman, Iris Breitkreutz, Peter Joosten, Christof Scheid, Marinus van Marwijk-Kooy, Hans-Juergen Salwender, Marinus H.J. van Oers, Ron Schaafsma, Ralph Naumann, Harm Sinnige, Igor Blau, Michel Delforge, Okke de Weerdt, Pierre Wijermans, Shulamiet Wittebol, Ulrich Duersen, Edo Vellenga, Hartmut Goldschmidt
Publikováno v:
Haematologica, Vol 93, Iss 1 (2008)
In the prospective phase 3 HOVON-50/GMMG-HD3 trial, patients randomized to TAD (thalidomide, doxorubicin, dexamethasone) had a significantly higher response rate (at least PR) after induction compared with patients randomized to VAD (vincristine, adr
Externí odkaz:
https://doaj.org/article/cde5267fd127455282cfd518e36718c1
Autor:
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W. C. J. van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Fredrik Schjesvold, Claudio Cerchione, Sonja Zweegman, Roman Hajek, Philippe Moreau, Hermann Einsele, Jesus San-Miguel, Mario Boccadoro, Meletios A. Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Publikováno v:
Leukemia. 37(6):1175-1185
In the post-pandemic COVID-19 period, human activities have returned to normal and COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an increased risk for breakthrough infections and severe COVID-19 outcomes, inclu
Autor:
Josien C. Regelink, Gerben J. C. Zwezerijnen, Richard J. W. Groen, Pieter G. Raijmakers, Sonja Zweegman
Publikováno v:
Regelink, J C, Zwezerijnen, G J C, Groen, R J W, Raijmakers, P G & Zweegman, S 2022, ' In vivo 18 F-fluoride-PET imaging reveals pronounced heterogeneity in bone formation in multiple myeloma patients ', British Journal of Haematology . https://doi.org/10.1111/bjh.18588
British Journal of Haematology. Wiley-Blackwell
British Journal of Haematology. Wiley-Blackwell
Autor:
Heinz Ludwig, Evangelos Terpos, Niels van de Donk, Maria-Victoria Mateos, Philippe Moreau, Melitios-Athanasios Dimopoulos, Michel Delforge, Paula Rodriguez-Otero, Jesús San-Miguel, Kwee Yong, Francesca Gay, Hermann Einsele, Roberto Mina, Jo Caers, Christoph Driessen, Pellegrino Musto, Sonja Zweegman, Monika Engelhardt, Gordon Cook, Katja Weisel, Annemiek Broijl, Meral Beksac, Jelena Bila, Fredrik Schjesvold, Michele Cavo, Roman Hajek, Cyrille Touzeau, Mario Boccadoro, Pieter Sonneveld
Publikováno v:
Ludwig, H, Terpos, E, van de Donk, N, Mateos, M-V, Moreau, P, Dimopoulos, M-A, Delforge, M, Rodriguez-Otero, P, San-Miguel, J, Yong, K, Gay, F, Einsele, H, Mina, R, Caers, J, Driessen, C, Musto, P, Zweegman, S, Engelhardt, M, Cook, G, Weisel, K, Broijl, A, Beksac, M, Bila, J, Schjesvold, F, Cavo, M, Hajek, R, Touzeau, C, Boccadoro, M & Sonneveld, P 2023, ' Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma : a consensus report of the European Myeloma Network ', The Lancet Oncology, vol. 24, no. 6, pp. e255-e269 . https://doi.org/10.1016/S1470-2045(23)00159-6
T-cell redirecting bispecific antibodies (BsAbs) and chimeric antigen receptor T cells (CAR T cells) have revolutionised multiple myeloma therapy, but adverse events such as cytokine release syndrome, immune effector cell-associated neurotoxicity syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c69c235f7b80581c27e00b535d9c87c
https://research.vumc.nl/en/publications/7309a3ce-8464-4f46-a5d1-df7372a43951
https://research.vumc.nl/en/publications/7309a3ce-8464-4f46-a5d1-df7372a43951
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
Autor:
Davine Hofste op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H.J. van der Velden, Remco Hoogenboezem, Bronno van der Holt, H. Berna Beverloo, Erik T. Valent, Michael Vermeulen, Francesca Gay, Annemiek Broijl, Hervé Avet-Loiseau, Nikhil C. Munshi, Pellegrino Musto, Philippe Moreau, Sonja Zweegman, Niels W.C.J. van de Donk, Pieter Sonneveld
Publikováno v:
Hofste op Bruinink, D, Kuiper, R, van Duin, M, Cupedo, T, van der Velden, V H J, Hoogenboezem, R, van der Holt, B, Beverloo, H B, Valent, E T, Vermeulen, M, Gay, F, Broijl, A, Avet-Loiseau, H, Munshi, N C, Musto, P, Moreau, P, Zweegman, S, van de Donk, N W C J & Sonneveld, P 2022, ' Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 27, pp. 3132-3150 . https://doi.org/10.1200/JCO.21.01217
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(27), 3132-3150. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(27), 3132-3150. American Society of Clinical Oncology
PURPOSE Primary plasma cell leukemia (pPCL) is an aggressive subtype of multiple myeloma, which is distinguished from newly diagnosed multiple myeloma (NDMM) on the basis of the presence of ≥ 20% circulating tumor cells (CTCs). A molecular marker f
Autor:
Tuna Mutis, Richard W.J. Groen, Maria Themeli, Niels W.C.J. van de Donk, Sonja Zweegman, Fengzhi Li, Susan E. van Hal-van Veen, Esther Drent, Anne T. Gelderloos, Renée Poels, Afroditi Katsarou, Jort J. van der Schans, Lisa C. Holthof
Table providing information on scFv sequences CARs. Figures providing data on CAR T cell phenotype, BMMSC survival, target antigen expression, cytotoxic mediator measurements, Survivin and Mcl-1 expression in MM cells, effector cell survival, and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8344fac75e21eea78a873d8ab5c0504b
https://doi.org/10.1158/1078-0432.22481549.v1
https://doi.org/10.1158/1078-0432.22481549.v1
Autor:
Niels W.C.J. van de Donk, Tuna Mutis, A. Kate Sasser, Henk M. Lokhorst, Torben Plesner, Christopher Chiu, Richard W.J. Groen, Pino J. Poddighe, René J.P. Musters, Johan van Meerloo, Sonja Zweegman, Marloes E.C. Broekmans, Andries C. Bloem, Jeroen F. van Velzen, Berris van Kessel, Inger S. Nijhof, Kris A. Frerichs, Jakub Krejcik
Supplemental Methods, Supplementary Tables, Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0452721a8c1ab9f0e419e4de516be385
https://doi.org/10.1158/1078-0432.22462592
https://doi.org/10.1158/1078-0432.22462592
Autor:
Niels W.C.J. van de Donk, Tuna Mutis, Homer C. Adams, Sonja Zweegman, Kodandaram Pillarisetti, Francois Gaudet, Amy Axel, Jocelyn Sendecki, Bhavesh Vaidya, Rengasamy Boominathan, Christie P.M. Verkleij, Lisa C. Holthof, Martijn W. Heymans, Berris van Kessel, Jhon A. Marin Soto, Marloes E.C. Broekmans, Kristine A. Frerichs
Supplemental Methods; Supplemental Figure legends; Supplemental Table 1; Figure S1, S2, S3, S4, S5, S6, S7, S8 and S9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2a5d7abfd7787a086a2da6120b5b98
https://doi.org/10.1158/1078-0432.22477205.v1
https://doi.org/10.1158/1078-0432.22477205.v1